Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol-induced kindling model.
Long-term real life efficacy of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in a population using intermittent self-catheterization.
Poster 373 Paradoxically Increased Rigidity After Intrathecal Baclofen Injection in a Patient with Multiple Sclerosis: A Case Report.
Magnetic resonance imaging of experimental autoimmune encephalomyelitis in the common marmoset.
Cattle encephalon glycoside and ignotin reduced white matter injury and prevented post-hemorrhagic hydrocephalus in a rat model of intracerebral hemorrhage.
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Postural tremor and chronic inflammatory demyelinating polyneuropathy.
Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study.
The Oligodendrocyte-Specific Antibody "CC1" Binds Quaking 7.
Reprogramming A375 cells to induced‑resembled neuronal cells by structured overexpression of specific transcription genes.
Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
Special Issue: Myelin Repair.
Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis.
Imag(in)ing multiple sclerosis: Time to take better pictures.
Neuromyelitis optica spectrum initially diagnosed as antiphospholipid antibody myelitis.
Increasing Physical Activity and Participation in People with Multiple Sclerosis: A Review.
Stent-assisted coil embolization of challenging intracranial aneurysms: initial and mid-term results with low-profile ACCLINO devices.
Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists.
Urban traffic-derived nanoparticulate matter reduces neurite outgrowth via TNFα in vitro.
Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4).
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.
DNA damage in the oligodendrocyte lineage and its role in brain aging.
APE1/Ref-1 facilitates recovery of gray and white matter and neurological function after mild stroke injury.
Why use sex hormones in relapsing-remitting multiple sclerosis? - Authors' reply.
Loss of Hippocampal Oligodendrocytes Contributes to the Deficit of Contextual Fear Learning in Adult Rats Experiencing Early Bisphenol A Exposure.
Pages
« first
‹ previous
…
834
835
836
837
838
839
840
841
842
…
next ›
last »